Autoimmune polyendocrine syndrome type 1: Utility of KCNRG autoantibodies as a marker of active pulmonary disease and successful treatment with rituximab. - Popler J; Alimohammadi M; Kämpe O; Dalin F; Dishop MK; Barker JM; Moriarty-Kelsey M; Soep JB; Deterding RR (Pediatric pulmonology, 2012)